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Improved clonality detection in Hodgkin lymphoma using a semi-nested 
modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A 
paraffin-embedded tissue study 
 
[Background] The BIOMED-2 PCR protocols targeting IGH and IGK genes 
may be useful for detecting clonality in Hodgkin lymphoma (HL). The clonality 
detection rates, however, have not been very high with these methods using 
paraffin-embedded tumor sections. We previously described the usefulness of 
the semi-nested BIOMED-2 IGH assay in B-cell malignancies. In this study, we 
devised a novel semi-nested BIOMED-2 IGK assay. [Methods] Employing 58 
cases of classical HL, we carried out the standard BIOMED-2, BIOMED-2 
followed by BIOMED-2 re-amplification, and BIOMED-2 followed by 
semi-nested BIOMED-2, all targeting IGH and IGK, using paraffin-embedded 
tissues. [Results] In both IGH and IGK assays, semi-nested assays yielded 
significantly higher clonality detection rates than the standard assays and 
re-amplification assays. Clonality was detected in 13/58 (22.4%) classical HL 
cases using the standard IGH/IGK assays while it was detected in 38/58 
(65.5%) cases using semi-nested IGH/IGK assays. The detection rates were 
not associated with the HL subtypes, CD30-positive cell density, 
CD20-positive cell density, or Epstein–Barr virus (EBV) positivity. [Conclusion] 
Tumor clonality was detected in nearly two thirds of classical HL cases using 
semi-nested BIOMED-2 IGH/IGK assays using paraffin tumor sections. These 
semi-nested assays may be useful when the standard IGH/IGK assays fail to 
detect clonality in histopathologically suspected HLs. 
 
